{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:17:34Z","timestamp":1792700254931,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21YF1413700"],"award-info":[{"award-number":["21YF1413700"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772446"],"award-info":[{"award-number":["81772446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000371"],"award-info":[{"award-number":["82000371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.heliyon.2023.e15451","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:49:25Z","timestamp":1681879765000},"page":"e15451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["miR-21-5p prevents doxorubicin-induced cardiomyopathy by downregulating BTG2"],"prefix":"10.1016","volume":"9","author":[{"given":"Qingwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6587-6279","authenticated-orcid":false,"given":"Jiaxin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2093-9149","authenticated-orcid":false,"given":"Meiyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3121-1455","authenticated-orcid":false,"given":"Yan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e15451_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-pharmtox-030620-104842","article-title":"Preventing and treating anthracycline cardiotoxicity: new insights","volume":"61","author":"Sawicki","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"22","key":"10.1016\/j.heliyon.2023.e15451_bib2","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.heliyon.2023.e15451_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced cardiomyopathy","volume":"339","author":"Singal","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15451_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12012-022-09721-1","article-title":"Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches","volume":"22","author":"Sheibani","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15451_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/mol.119.115725","article-title":"Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring","volume":"96","author":"Wenningmann","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15451_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-030-43032-0_15","article-title":"Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention","volume":"1257","author":"Bhagat","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15451_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Simunek","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15451_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0024-3205(00)00990-5","article-title":"Effects by doxorubicin on the myocardium are mediated by oxygen free radicals","volume":"68","author":"Xu","year":"2001","journal-title":"Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2023.e15451_bib9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mgme.2000.3043","article-title":"Molecular basis of anthracycline-induced cardiotoxicity and its prevention","volume":"71","author":"Horenstein","year":"2000","journal-title":"Mol. Genet. Metabol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15451_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15451_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-009-0051-8","article-title":"Cardiomyocyte death in doxorubicin-induced cardiotoxicity","volume":"57","author":"Zhang","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15451_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031414","article-title":"Therapeutic targets for DOX-induced cardiomyopathy: role of apoptosis vs. Ferroptosis","volume":"23","author":"Kitakata","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15451_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Circu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.heliyon.2023.e15451_bib14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.omtn.2020.10.014","article-title":"Trophoblast stem-cell-derived exosomes improve doxorubicin-induced dilated cardiomyopathy by modulating the let-7i\/YAP pathway","volume":"22","author":"Ni","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15451_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12951-020-00733-z","article-title":"Human trophoblast-derived exosomes attenuate doxorubicin-induced cardiac injury by regulating miR-200b and downstream Zeb 1","volume":"18","author":"Ni","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15451_bib16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2023.e15451_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.vph.2018.10.010","article-title":"Elucidating the contributory role of microRNA to cardiovascular diseases (a review)","volume":"114","author":"Johnson","year":"2019","journal-title":"Vasc. Pharmacol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15451_bib18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/aps.2018.30","article-title":"miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15451_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jshs.2020.03.004","article-title":"The roles of microRNA in redox metabolism and exercise-mediated adaptation","volume":"9","author":"Torma","year":"2020","journal-title":"J. Sport Health Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15451_bib20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.ymthe.2022.01.031","article-title":"miR-486 attenuates cardiac ischemia\/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection","volume":"30","author":"Bei","year":"2022","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15451_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s12265-021-10116-w","article-title":"Dickkopf 3: a novel target gene of miR-25-3p in promoting fibrosis-related gene expression in myocardial fibrosis","volume":"14","author":"Zeng","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15451_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12265-020-10065-w","article-title":"MicroRNA-151 attenuates apoptosis of endothelial cells induced by oxidized low-density lipoprotein by targeting interleukin-17a (IL-17A)","volume":"14","author":"Chen","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15451_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12265-020-10040-5","article-title":"Cardiovascular exosomes and MicroRNAs in cardiovascular physiology and pathophysiology","volume":"14","author":"Henning","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.heliyon.2023.e15451_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1055911","article-title":"MicroRNAs in doxorubicin-induced cardiotoxicity: the DNA damage response","volume":"13","author":"Kawano","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15451_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","article-title":"MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf 2 and Sirt2","volume":"15","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.heliyon.2023.e15451_bib26","article-title":"miR-451 silencing inhibited doxorubicin exposure-induced cardiotoxicity in mice","volume":"2019","author":"Li","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15451_bib27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41419-019-1901-x","article-title":"miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b\/P53 pathway in doxorubicin-induced cardiotoxicity","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15451_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-021-00272-1","article-title":"miR-21: a non\u2010specific biomarker of all maladies","volume":"9","author":"Jenike","year":"2021","journal-title":"Biomark. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15451_bib29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and function of miRNA-21 in health and disease","volume":"8","author":"Kumarswamy","year":"2011","journal-title":"RNA Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15451_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040711","article-title":"Overexpression of exosomal cardioprotective miRNAs mitigates hypoxia-induced H9c2 cells apoptosis","volume":"18","author":"Zhang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15451_bib31","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1172\/JCI123135","article-title":"microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential","volume":"129","author":"Qiao","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15451_bib32","doi-asserted-by":"crossref","first-page":"14511","DOI":"10.3390\/ijms160714511","article-title":"MiR-21 protected cardiomyocytes against doxorubicin-induced apoptosis by targeting BTG2","volume":"16","author":"Tong","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15451_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cmet.2015.02.014","article-title":"miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling","volume":"21","author":"Liu","year":"2015","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15451_bib34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15451_bib35","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1002\/jcp.27407","article-title":"Tumor suppressors BTG1 and BTG2: beyond growth control","volume":"234","author":"Yuniati","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15451_bib36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/ijo.2014.2765","article-title":"BTG2: a rising star of tumor suppressors (review)","volume":"46","author":"Mao","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15451_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/med.21280","article-title":"Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy","volume":"34","author":"Carvalho","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15451_bib38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12032-012-0376-8","article-title":"MicroRNA-21 gene and cancer","volume":"30","author":"Huang","year":"2013","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15451_bib39","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2010-01-263889","article-title":"microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival","volume":"116","author":"Rossi","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15451_bib40","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1517\/14728222.2010.527334","article-title":"Targeting miR-21 in glioma: a small RNA with big potential","volume":"14","author":"Moore","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15451_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","article-title":"miR-21: a small multi-faceted RNA","volume":"13","author":"Krichevsky","year":"2009","journal-title":"J. Cell Mol. Med."},{"issue":"Pt 4","key":"10.1016\/j.heliyon.2023.e15451_bib42","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1042\/BST0370918","article-title":"miR-21 as a key regulator of oncogenic processes","volume":"37","author":"Selcuklu","year":"2009","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15451_bib43","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3892\/ijo.2015.2841","article-title":"Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes","volume":"46","author":"Zhang","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15451_bib44","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.3892\/mmr.2014.2068","article-title":"microRNA-21 protects against ischemia-reperfusion and hypoxia-reperfusion-induced cardiocyte apoptosis via the phosphatase and tensin homolog\/Akt-dependent mechanism","volume":"9","author":"Yang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15451_bib45","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.7150\/thno.29945","article-title":"Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction","volume":"9","author":"Song","year":"2019","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15451_bib46","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1002\/jcp.26854","article-title":"Nucleolin protects against doxorubicin-induced cardiotoxicity via upregulating microRNA-21","volume":"233","author":"Sun","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15451_bib47","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1078-0432.CCR-12-3325","article-title":"Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth","volume":"19","author":"Leone","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15451_bib48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/jcmm.16110","article-title":"miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2","volume":"25","author":"Vandewalle","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"7360","key":"10.1016\/j.heliyon.2023.e15451_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023026580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023026580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:17:44Z","timestamp":1773397064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023026580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2405844023026580"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15451","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-21-5p prevents doxorubicin-induced cardiomyopathy by downregulating BTG2","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e15451"}}